Stopping Eliquis: Stroke Risk And Prevention

Eliquis (apixaban) is a prescription medicine used to reduce the risk of stroke and blood clots in people with atrial fibrillation (AFib), a type of irregular heartbeat. It is also used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE), and to prevent DVT or PE from recurring.

Stopping Eliquis treatment early can increase the risk of blood clots and, if you have AFib, it can also increase the risk of having a stroke. This is because Eliquis is a blood thinner that works by reducing the blood's ability to form clots. Therefore, stopping the medication can lead to dangerous bleeding risks.

It is important to speak to your doctor before stopping Eliquis, as they may recommend a different medication to help prevent blood clots while you are not taking Eliquis.

Eliquis is a prescription medicine used to treat blood clots and reduce the risk of them occurring again

Eliquis contains the active ingredient apixaban and belongs to the anticoagulant (blood thinner) drug class. It is available in tablet form, in the following doses: 2.5 mg and 5 mg. The recommended dose of Eliquis is 5 mg orally twice daily. For elderly patients 80 years of age or older, weighing 60 kg or less, or having serum creatinine equal to or above 1.5 mg/dL, the recommended dose is 2.5 mg orally twice daily.

Eliquis can cause certain side effects, some of which are more common than others. These side effects may be temporary, lasting a few days to weeks. However, if the side effects last longer, bother you, or become severe, be sure to talk with your doctor or pharmacist. Some of the more common side effects reported by people who took Eliquis in clinical trials include increased bleeding risk, minor bleeding, and mild allergic reactions.

Serious side effects of Eliquis include severe allergic reactions, spinal blood clots with spinal procedures, and increased risk of blood clots if treatment is stopped early. Eliquis has boxed warnings for the risk of spinal blood clots with spinal procedures and the increased risk of blood clots if treatment is stopped early. These are serious warnings from the Food and Drug Administration (FDA).

It is important to note that stopping Eliquis treatment will increase your risk of a stroke if you were taking it for atrial fibrillation. Speak to your doctor for medical advice if you are considering stopping Eliquis.

Eliquis is a blood thinner that can increase the risk of bleeding

Eliquis works by interfering with the process of blood clotting. It does this by preventing "clotting factors" in the blood from working. While this can help to prevent dangerous blood clots, it also increases the risk of bleeding. This is because the body needs some clotting ability to prevent major bleeding events.

The most common side effects of Eliquis related to bleeding include:

• Increased bruising
• Bloody or brown urine
• Bloody or tarry stools
• Bleeding from the anus or vagina
• Vomiting blood
• Unusual nosebleeds

Other possible side effects include:

• Joint pain or swelling
• Shortness of breath or wheezing

In rare cases, Eliquis can cause serious bleeding, such as internal bleeding in the digestive system, lungs, brain, liver, kidneys, abdominal cavity, joints, or eyes. It can also cause bleeding from a damaged blood vessel that builds up and clots in the surrounding tissues, causing a swelling called a hematoma.

It is important to note that stopping Eliquis treatment can also increase the risk of blood clots and stroke. This is because the body will return to clotting at its normal, faster rate. Therefore, it is recommended that people do not stop taking Eliquis unless advised to do so by their doctor.

Eliquis is not suitable for people with kidney or liver disease

Eliquis is a prescription drug used to treat and prevent blood clots and strokes in people with nonvalvular atrial fibrillation (AFib). AFib is a type of irregular heartbeat that increases the risk of blood clots forming in the heart. Eliquis is also used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE).

While Eliquis is generally well-tolerated, it is not suitable for everyone. People with kidney or liver disease, in particular, should not take Eliquis. This is because Eliquis can build up in the body if the liver is not functioning properly, increasing the risk of side effects. Similarly, if the kidneys are not working effectively, Eliquis can accumulate in the body, leading to a higher risk of adverse effects.

In addition, Eliquis may not be suitable for those with:

• Bleeding problems: Eliquis increases the risk of bleeding, so it is not recommended for those with current bleeding issues.
• Upcoming surgical, medical, or dental procedures: Eliquis can increase the risk of bleeding during procedures, so it may need to be paused temporarily.
• Triple-positive antiphospholipid syndrome (APS): Eliquis may increase the risk of blood clots in people with this condition.
• Allergic reaction: Those who have had a severe allergic reaction to Eliquis or its ingredients should not take it.
• Artificial heart valve: Eliquis has not been studied in people with artificial heart valves.
• Pulmonary embolism (PE) requiring surgery or clot-dissolving medication: Eliquis is not recommended for PEs needing surgical or pharmacological intervention.
• Pregnancy and breastfeeding: It is unknown whether Eliquis is safe during pregnancy and breastfeeding.

It is important to consult a healthcare professional before taking Eliquis to ensure it is suitable for your individual circumstances. They will assess your health history and determine if Eliquis is the right treatment option for you.

Eliquis may need to be stopped before surgery to reduce the risk of bleeding

Eliquis is a prescription medicine used to reduce the risk of blood clots and strokes in people with nonvalvular atrial fibrillation (AFib). AFib is a type of irregular heartbeat that is not caused by a heart valve problem. Eliquis contains the active ingredient apixaban and belongs to the anticoagulant (blood thinner) drug class.

If you have a surgery planned, talk with your doctor about when you should stop taking Eliquis. You should not stop taking Eliquis unless your doctor tells you to. Your doctor may prescribe a different medication to prevent blood clots during the time you can't take Eliquis.

The withdrawal of antiplatelet and antithrombotic medications in the 60 days preceding an acute ischemic stroke was associated with 5.2% of ischemic strokes in one study. This finding emphasizes the need for thoughtful decision-making concerning antithrombotic medication use in the periprocedural period and efforts to improve patient compliance.

The risk of bleeding during surgery is higher if you are taking Eliquis because this drug makes it harder for your blood to form clots. While taking Eliquis, you may notice that you bruise or bleed more easily than usual. Also, it might take longer than usual for bleeding to stop.

Bleeding is the most common side effect of Eliquis. In clinical studies, the rates and severity of bleeding varied depending on the dosage and the condition being treated.

Stopping Eliquis treatment can increase the risk of blood clots and stroke

Eliquis (apixaban) is a prescription medicine used to reduce the risk of blood clots and stroke in people with atrial fibrillation (AFib). AFib is a type of irregular heartbeat that is not caused by a heart valve problem. Eliquis is also used to treat blood clots in the veins of the legs (deep vein thrombosis) or lungs (pulmonary embolism) and to prevent them from occurring again.

It is important to note that Eliquis should not be stopped without first consulting a doctor. Stopping Eliquis treatment may increase the risk of a heart attack, stroke, pulmonary embolism, or deep vein thrombosis. If Eliquis is stopped, the risk of blood clots and stroke returns to what it was before treatment within a few days.

In addition, stopping Eliquis treatment may increase the risk of bleeding. Eliquis can cause an increased risk of bleeding because it interferes with the blood's ability to clot. This effect can last for up to 24 hours after stopping treatment.

It is important for patients to consult their doctor before stopping Eliquis treatment to weigh the risks and benefits and to determine if alternative treatments are needed to prevent blood clots and stroke.

Frequently asked questions